AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From CBS Marketwatch (Stories))
WASHINGTON (CBS.MW) -- The U.S. Food and Drug Administration has warned Pfizer in a letter that its ads for arthritis drugs Celebrex and Bextra are misleading.
The FDA said in a letter dated Jan. 10 and released on Wednesday that Pfizer failed to disclose information on risks in different advertising campaigns and made "unsubstantiated effectiveness claims" in its ads. The letter alleged Pfizer violated provisions of the U.S. Food, Drug and Cosmetic Act.
Joan Hankin, an FDA consumer promotion analyst, sent a letter to Robert B. Clark, Pfizer's vice president of regulatory affairs. In it, she said the agency focused …